human clinical trials bpc 157 bpc-157 studies randomized trial for ACL recovery: hype vs. science bpc 157 human clinical trial

, BPC-157

In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing

Based on these results, we proposed a Funnel model incorporating both assays for efficient early-stage screening of BBB-permeable compounds (Figure 4)

You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries